♫musicjinni

From Silicon Valley to Cell Biology - AI in Drug Design

video thumbnail
The interaction of computers, artificial intelligence, and biology is growing every day, with news of computer-brain interfaces, computer-aided drug design, and Google's AlphaFold for protein structure prediction.

Erika Alden DeBenedictis discussed three innovations that are changing the world of biology: machine learning models that can predict properties of biological systems, robotic systems for conducting reproducible experiments, and new types of institutions that alter the incentives of scientists themselves. Kevin Gardner describes his work on solving atomic-level pictures and mechanisms of proteins used by cells to sense and respond to changes in the environment around them. This work not only leads to better understanding of biology, but also establishes new biotech tools and therapies.

Our speakers include:

Erika Alden DeBenedictis (she/her): The new era of computer-aided science
Erika is a former astronomer, recovering computer scientist, and current synthetic biologist. During her PhD at MIT Biological Engineering, she studied the origins of life, and developed robotic systems for engineering bacteria. Erika recently launched the 2022 Bioautomation Challenge, a grant program that gives researchers access to cloud laboratories in order to improve reproducibility, scalability, and shareability of life science research with programmable experiments. Find her at: twitter.com/erika_alden_d


Kevin Gardner (he/him): Nature's switches = Inspiration for new biotech tools and disease-fighting drugs
Director of Structural Biology, CUNY Advanced Science Research Center, and Einstein Professor of Chemistry & Biochemistry, City College of New York.
B.S. Biochemistry, UC Davis; Ph.D. Molecular Biophysics & Biochemistry, Yale (w/Joe Coleman); postdoc Univ Toronto (w/Lewis Kay). Started independent group at UT Southwestern Med Center in Dallas, moved to CUNY in 2013. Started two companies (Peloton Therapeutics, Optologix) to help commercialize aspects of what will be discussed tonight. Find him at: twitter.com/nmrkaygee

Penn Structural Biology: The Future of Drug Discovery

We’re Teaching Robots and AI to Design New Drugs

Webinar: Application of Artificial Intelligence to Structural-Functional Biology and Drug Design

Machine Learning for Drug Discovery (Explained in 2 minutes)

Generative AI in Biology and Healthcare | GTC 2023

From Silicon Valley to Cell Biology - AI in Drug Design

Daphne Koller: AI-Driven Drug Discovery Using Digital Biology | TransformX 2022

Machine Learning: A new approach to drug discovery

Transforming Drug Discovery using Digital Biology Daphne Koller

Menten AI: Designing Peptide Therapeutics on a Quantum Computer

Transforming Drug Discovery Using Machine Learning

AI Vs. Drug Resistance

Using open science to accelerate drug development: Meet Aled | The Disruptors

The Impact of Biology on Health and Developing Medicines

Benefits of using PubChem in Computational Drug Discovery projects. #cancer #bioinformatics

Python for Bioinformatics - Drug Discovery Using Machine Learning and Data Analysis

AlphaFold 3: AI Revolution in Cell Biology

7.3. Systems Biology - Rational Drug Design

The Drug Discovery Process

Optimal Transport Modeling of Population Dynamics in Single-Cell Biology - Charlotte Bunne

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

Part 2. AI Cell Biology, Generative AI and Exosomes: The Future of Cancer Treatment

How Amgen is using Generative Biology and AI

Challenging Biology: can we code human cells for health? | Dr. Mark Kotter | TEDxCambridgeUniversity

Prof Michele Vendruscolo Presentation for AI and ML in Drug Design and Discovery Showcase 2022

StateOfTheArt() - AI Meets Biology

Harnessing Chemical Biology for Cancer Drug Discovery with Michael Erb, PhD

Will AI Revolutionize Medicine?

Machine Learning Based Biological Experimental and Therapeutics Design: Online Symposium

BioWednesday Webinar: Enabling AI in Drug Discovery

Disclaimer DMCA